NEW YORK, Feb. 24 (GenomeWeb News) - Evogene has raised another $1.5 million in a second closing of its first private placement, the company said today.


The second closing brings the total amount of the first round to $3.5 million, after the first closing in March of 2003.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.